In predominantly non-metastatic and well-differentiated/intermediate grade PanNETs, however, loss of DAXX/ATRX by IHC correlated with higher tumor grade and stage, risk for metastasis, and worse survival [6, 7]. The gene discussed is ATRX; the disease is neoplasm.